Orchid Chemicals & Pharmaceuticals Ltd.
Unaudited Financial Results for the quarter ended June 30, 2009
S.No
Particulars
Three Months ended
30-Jun-09 (Unaudited)
Three Months ended
30-Jun-08 (Unaudited)
Year ended
31-Mar-09 (Audited)
1
 Net Sales
30,581.89

28,255.12
115,676.96
2
 Other Operating Income
301.17
2,376.80
5,450.12
3
Total Operating Income (1+2)
30,883.06
30,631.92
121,127.08
4
 Expenditure      

a) Decrease/(Increase) in Stock in trade
(2,677.99)
(5,656.16)
(6,478.32)
b) Material Cost
12,708.86
14,344.91
53,881.65
c) Purchase of Trades Goods
871.06
996.57
3,627.66
 
d) Employees Cost
2,896.22
2,874.81
12,288.43
 
e) Depreciation / Amortisation
3,732.56
3,117.64
12,997.21
  f) Exchange rate loss/(gain)
2,998.43
(349.73)
1,568.35
 
f) Other Expenditure
7,594.75
9,588.93
27,667.07
g) Total
28,123.89
24,916.97
105,552.05
5
Profit from Operations before other Income, Interest & Exceptional Item (3 - 4)
2,759.17
5,714.95
15,575.03
6
Other Income
0.46
0.74
301.85
7
Profit before Interest & Exceptional Item (5+6)
2,759.63
5,715.69
15,876.88
8
 Interest & Finance Charges
5,166.30
3,024.48
15,518.60
9
Profit/(loss) after interest but before Exceptional Item (7-8)
(2,406.67)
2,691.21
358.28
10
Exceptional Item
(363.54)
(5,879.72)
(4,043.10)
11

Profit/ (Loss) before Tax (9+10)
(2,770.21)
(3,188.51)
(3,684.82)
12
Tax expenses
     - Current Tax & Deferred Tax
205.84
(58.91)
1,371.65
     - Fringe Benefit Tax
-
35.00
161.00
13
 Net Profit/ (Loss) after Tax (11-12)
(2,976.05)
(3,164.60)
(5,217.47)
14
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
7,044.21
6,587.66
7,044.21
15
 Reserves excluding Revaluation Reserves
59,977.31
16
 Basic Earnings per Share (EPS) Rs.
(4.22)*
(4.80)*
(7.61)
17
Diluted Earnings per share (EPS) Rs.
(4.22)*
(4.80)*
(7.61)
18
Aggregate of Public Shareholding
     - Number of equity shares
55525904
55522404
55525904
     - Percentage of Shareholding
78.82
84.28
78.82
19
Promoters and Promoter group shareholding
a. Pledged / Encumbered
- Number of shares
4158000
6258000
 
- Percentage of shares (as a % of the total shareholding of promoter and promoter group)
27.88
41.95
 
- Percentage of shares (as a % of the total share capital of company)
5.90
8.88
 
b. Non - Encumbered
 
- Numbers of shares
10758172
8658172
 
- Percentage of shares (as a % of the total shareholding of promoter and promoter group)
72.12
58.05
 
- Percentage of shares (as a % of the total share capital of company)
15.28
12.30
* EPS for the period (not annualised)
  1. The above unaudited financial results were approved by the Board of Directors at its meeting held on Friday, July 31, 2009 and have been subjected to limited review by the Statutory Auditors.
  2. The Company is operating in single segment (i.e) "Pharmaceuticals".
  3. The Company has exercised the option provided under the Companies (Accounting Standards) Amendment Rules, 2006 dated 31st March 2009 in respect of AS 11. The amount remaining to be amortized in the financial statements as on 30th June 2009 on account of exercising the above option is Rs 2700.33 lakhs. If the same policy had been followed for the period ended 30th June 2008, then the profit before tax would be Rs.3360.26 lakhs and profit after tax would be Rs.2944.54 lakhs against the reported figures for the period ended 30th June 2008.
  4. Exceptional items for the quarter ending June 30, 2009 & 2008 represents exchange losses on FCCBs.
  5. The Company received 7 complaints during the quarter ended June 30, 2009 from the shareholders. All the complaints have been resolved and no complaints were pending as on June 30, 2009.
  6. Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : 31-07-2009

For and on behalf of the Board

K. Raghavendra Rao
Managing Director